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Abstract 
 
Mucormycosis is a rare fungal infection caused by organisms of the order Mucorales often occurring in diabetics 
or immunologically compromised patients. To date, only one case of primary mucormycosis of breast has been 
reported in the English literature. We describe a further case of mucormycosis that was localized to the breast in 
a patient with no underlying disease and was successfully treated with a simple mastectomy and intravenous 
antifungal therapy. 
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Introduction 
 
Mucormycosis is a rare fungal infection caused by or-
ganisms of the order Mucorales often occurring in dia-
betics or immunologically compromised patients but 
the individuals without an obvious underlying predis-
posing factor can rarely be involved with this disease.
1 
Once infection has occurred, the fungus invade the 
vasculature and leads to thrombosis and tissue ischemia 
and finally necrosis with a high mortality rate.
2,3 With 
aggressive surgical debridement, control of comorbidi-
ties such as hyperglycemia and immunosuppression, 
and the use of modern antifungal agents, survival rates 
for invasive mucormycosis are 36% to 50%.
4 
To date, only one case of primary mucormycosis 
of breast has been reported in the English literature.
5 
We describe a further case of mucormycosis that was 
localized to the breast in a patient with no underlying 
disease and was successfully treated with a simple 
mastectomy and intravenous antifungal therapy. 
 
 
Case Report 
 
A 75 year old female presented gradual onset of pain, 
redness and swelling of the left breast with 7 days 
duration without any history of trauma, diabetes mellitus 
or other chronic diseases. She did not take any medica-
tion. On examination, she was febrile and had pulse rate 
of 90 beats/minute and blood pressure of 110/80 mmHg. 
Her left breast was swollen, red, tender and warm with a 
necrotic lesion of 3x4 cm. Investigations revealed a he-
moglobin concentration of 12 gm% with a white cell 
count of 18,500/cu.mm. Renal and liver function tests 
were within normal limits as was the chest radiograph. 
A diagnosis of severe mastitis with probable abscess 
was made. An incision was taken over the breast to 
drain the underlying pus collections if any but there 
were no localized abscess (Figure 1).  
 
 
Fig. 1: Incision was taken over the breast to drain 
underlying pus collections and debridement of necrotic 
tissue of breast was done. 
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However, within 24 hours the underlying breast 
tissue showed necrosis with black eschar formation. 
An incisional biopsy revealed breast parenchymal 
necrosis, polymorphonuclear infiltration and several 
broad aseptate hyaline fungal hyphae. A simple mas-
tectomy was done. Histopathological examination 
showed extensive necrosis of the breast parenchyma 
with polymorphonuclear infiltration, hemorrhage and 
thrombosed blood vessels and many broad aseptate 
hyaline fungal hyphae branching at 90
o suggestive of 
mucormycosis (Figure 2).  
 
 
Fig. 2: Histopathological findings. Microscopic view of 
the biopsy specimen shows several short folded hy-
phae with non-septate broad and right angle bud-
dings which are characteristic for mucormycosis. PAS 
was negative (H&E, 1200X). 
 
Intravenous amphotericin-B (1 mg/kg/day in the 
form of infusion in 5% dextrose) was administered 
for 10 days followed by one month fluconazole 
treatment. The patient showed complete remission 
after one week. We grafted the wound with split 
thickness skin graft after one month. She was asymp-
tomatic during her 3 months follow up. 
 
 
Discussion 
 
Mucormycosis is caused
 by various members of the 
phycomycetes, such as rhizopus, mucor,
 and absidia.
6 
They are usually found in soil, spoiled foods, bread, 
and dust, so most individuals are exposed to these 
fungi on a daily basis but most often diabetics or pa-
tients with immunosuppressed conditions like chronic 
steroid use, metabolic acidosis, organ transplantation, 
leukemia/lymphoma, treatment with deferoxamine, 
and AIDS are susceptible to this infection.
1 
In our patient, spores were likely to have gained 
entry to breast through unknown trauma and multi-
plied and invaded the breast tissue. The predisposing 
factor making our patient susceptible to this infection 
was not clear. Old age is the only factor which may 
result to a immunocompromised situation. Although 
there are some reports in the literature that patients 
without underlying disease may develop mucormyco-
sis too.
1 Mucormycosis often manifests as a rhinoor-
bitocerebral, pulmonary, gastrointestinal, cutaneous, 
or disseminated disease.
1 There are cases of cutane-
ous mucormycosis after minor trauma but these pa-
tients had diabetes as an underlying disease.
7,8  
Invasive surgical debridement with systemic am-
photericin B led to a favorable response in our pa-
tient. To our knowledge, only one other report of 
primary breast mucormycosis has been reported.
5  In 
that report, they used simple mastectomy followed 
by amphotricin B therapy, as we did, and their result 
was successful. 
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